TABLE 5.
Prognosis of Recurrent and Advanced Cases of Non-Hodgkin’s Lymphoma (Takai et al., 1991; Takai, 1992)
| Age/sex | Stage | Primary site | Treatment method | Response | Survival, months | Present status | Cause of death |
|---|---|---|---|---|---|---|---|
| 36/M | IV | Axilla | TBI+Local | PD | 1 | Dead | Pancytopenia |
| 69/F | IV | Neck | TBI+Local | PD | 1 | Dead | Pancytopenia |
| 57/M | III | Neck | TBI+Local | PD | 2 | Dead | Leukenic change |
| 56/M | IV | Cecum | TBI only | PD | 1 | Dead | Thrombocytopenia |
| 61/F | III | Neck | TBI+Local | PD | 1 | Dead | Leukenic change |
| 45/M | IV | Smallintestine | TBI+Local | PD | 1 | Dead | Cancerous peritonitis |
| 52/F | IV | Inguinal | TBI+Local | PD | 2 | Dead | Pancytopenia |
| 62/M | II | Neck | TBI+Local | NC | 2 | Alive | |
| 46/M | III | Neck | TBI+Local | PR | 3 | Alive | |
| 83/M | II | Skin | TBI-Chemo | CR | 7 | Alive | |
| 55/M | II | Tonsil | TBI+Local-Chemo | CR | 8 | Alive |
Chemotherapy followed a few months later as a boost therapy after completing radiotherapy. PD: progression of disease, NC: no change, PR: partial response, CR: complete response. Survival results observed in 1995.